Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B-SIMPLE2: SB206 for Molluscum Contagiosum
NCT03927703Phase 3Completed
- Sponsor
- Novan
- Start
- Jun 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of daprodustat in molluscum contagiosum (MC) (2 arms), sponsored by Novan. Primary endpoint: Complete Clearance of All Treatable MC at Week 12. Started Jun 2019; status: completed.
02
Drugs
daprodustat
03
Conditions
molluscum contagiosum (MC)
Beyond the preview
Go deeper on NCT03927703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03927703.